Ketoconazole has approval for use in the treatment of fungal infections of the skin and systemic fungal infections.

The use of this drug requires a careful risk-benefit analysis when selecting ketoconazole as the treatment of fungal infections. Clinicians should avoid using ketoconazole in the treatment of onychomycosis, cutaneous dermatophyte, and candida infections.